Bleepa achieves CE Mark - Raising the bar for medical communication platforms

Bleepa one of DIT Digital Health First 100 Companies

25/02/21

Bleepa Feedback Medical Feedback PLC

Bleepa is one of 100 companies featured in the Department for International Trade‘s (DIT) Digital Health First 100 Companies playbook, launched on Wednesday 24 February 2021. With UK companies at the heart of technologies that offer accessible, affordable and sustainable care, the DIT is promoting British innovators in digital health who are ready to go global and link it with an ever expanding worldwide opportunity.

First 100

By promoting digital health to overseas buyers and creating business opportunities with its teams in 96 markets around the world, the DIT hopes through the First 100, to reach out to those who are not just leaders in their field, but those willing to find new frontiers to make an impact in building the basis for the healthcare of the future: personalised, digital by default and truly patient centric.

Following Bleepa’s inclusion in the DigitalHealth.London Accelerator programme, being part of the DIT global campaign further strengthens Bleepa’s position and exposure in both the NHS and international markets.

Bleepa

“Being selected for the DigitalHealth.London Accelerator programme has opened a network, both of potential Bleepa customers but also fellow innovators in the medical digital field.  The work that the DIT and DigitalHealth.London are doing to promote entrepreneurial companies such as Feedback is so important to raising our profile and enabling routes into key markets, including the wider NHS audience, as well as international markets such as India where we are making great progress following a DIT mission. In combination, these platforms are helping to showcase the best British technology to the NHS and the world, it is great to see Bleepa front and centre of these discussions. 

“The DIT Digital Health First 100 companies’ campaign highlights Bleepa’s role in transforming healthcare through digital innovation and potential as a key UK export. We not only appreciate their ongoing support of our business, but also recognise their validation of our product can speak volumes to leaders in healthcare. We look forward to continuing to build on this collaborative work together to build a better, stronger and more intuitive approach to healthcare.” Dr Tom Oakley, CEO